Sanderling Ventures VII (Canada), LP

Founded in 1979, Sanderling Ventures is amongst the oldest and most established North American venture firms focused exclusively on biomedical investing. We invest in therapeutics, medical devices and information health.

Sanderling has consistently high rates of return across multiple vintage years with multiple top quartile funds.

In Canada, Sanderling utilizes Therillia Development Co., a Sanderling portfolio company based in Montreal, to manage the development of therapeutic assets held by other Sanderling portfolio companies. This model of “active management” utilizes the expertise of Therillia’s seasoned drug development team and has been successful in advancing multiple projects in a cost-effective manner.

Preview

General Information

  • Emailinfo@therillia.com
  • Adress 1010 Sherbrooke St. W., Suite 408 , Montreal H3A 2R7, QC ca

Nature of the activities

Types de fonds

  • Fund of funds

Nature des activités de financement et d'investissements

  • Development
  • Seed
  • Start-up

Secteurs d'activité

  • Life Sciences